About APCI Who We Are

A Manufacturing Technology Leader

Advanced Process Combinatorics, Inc. (APCI) was formed in 1993 using technology initially developed at Purdue University in close partnership with industry. Our specialty is the application of mathematical programming-based optimization to the process industries. Our products are unique and reflect the unique skill set of our personnel who are highly trained and experienced in both optimization and process engineering.

We have invested decades of research and development efforts into the solution of time-based resource management problems. We routinely solve difficult problems to help customers manage complexity in a way that is intuitive and promotes constant improvement. Over time this leads to a modeling culture and an approach to business that quickly takes advantage of opportunities and routinely overcomes challenges. If you want to use data to make decisions, be goal oriented, and take intuitive control of your business, you will choose APCI.

0+

YEARS

implementing design, planning, and scheduling solutions for some of the most complex processes in the world.

“VirtECS is a super tool in production scheduling, scenario planning, plant design, capacity planning, and supply planning for the long term.”

Vice President, Supply Chain

Large Chemical Company

OUR LEADERSHIP

EXPERIENCE SETS US APART

Dr. Joseph Pekny, Ph.D.

Co-Founder and CEO

Joe Pekny co-founded APCI in 1993. Dr. Pekny is also a Professor of Chemical Engineering at Purdue University, and was the Founding Director of the Regenstrief Center for Healthcare Engineering in 2005. For over twenty years he has been a leader in the application of industrial engineering techniques to complex industrial challenges, and has been a key leader in the development of products and services for combinatorial optimization for process design, planning, and scheduling. Pekny earned a Ph.D. in Chemical Engineering from Carnegie Mellon University in 1989.

Dr. Donald Miller, Ph.D.

Co-Founder and CFO

Don Miller co-founded APCI in 1993 after working for 16 years as an Optimization Engineer with DuPont. The seminal research of Drs. Miller and Pekny on the exact solution of large asymmetric traveling salesman problems (Science, 251, p754-761, 1991) led to the founding of APCI. Dr. Miller has been a lead developer in the algorithms which form the basis of the VirtECS scheduling engine. While at DuPont he developed steady-state simulation and optimization methods for production scheduling and process optimization. Miller earned a Ph.D. in Chemical Physics from University of Texas at Austin in 1985.

Dr. Stephen Harding, Ph.D.

President

Steve Harding joined APCI in 1999 while completing his doctoral thesis in the area of optimization-based process design. Dr. Harding has led the design and implementation of VirtECS tools to aid scheduling of many types of processes. Through his expertise in industrial engineering and optimization techniques he has helped transform VirtECS from an analytical tool into a business-critical application used on a daily basis at large manufacturing facilities. Harding earned a Ph.D. in Chemical Engineering from Princeton University in 2000.

Dr. Derrick Schertz, Ph.D.

Vice President

Derrick Schertz joined APCI in 2000 after completion of his doctorate in the area of advanced process scheduling. Dr. Schertz has worked extensively with pharmaceutical and biologics facilities, leading scheduling implementations as well as performing design/retrofit analysis integrated with scheduling considerations. He has also designed robust scheduling algorithms in the presence of process variability and led integration of customer data systems with VirtECS. Schertz earned a Ph.D. in Chemical Engineering from Purdue University in 1999.

Our History

Always evolving

1993
\
1993

Answering the Call

Founded to apply novel mathematical advances to current, inadequate planning and scheduling software available in the market.

1994
\
1994

Our First Customer

Developers create the first version of our VirtECS scheduling solver. Dow Elanco signs on as the first commercial business to implement VirtECS in a manufacturing site.

1995
\
1995

Process Modeling Begins

Working with Purdue University Industrial Consortium members such as Dow, P&G and Dupont. Many initial customers remain today.

1997
\
1997

The Scheduler evolves

Initial development begins on advancing our scheduling solver technology to utilize infinite dimensional programming.Ā 

1997
\
1997

Virtecs launches on Windows

The first Windows-basedĀ versionĀ ofĀ VirtECS becomes available, making the software more accessible for clients.

1999
\
1999

VIRTECS Enters the Pharma Industry

Eli Lilly becomes the first pharmaceutical company to implement VirtECS.

2003
\
2003

Accomodating complexity

Development continues fully owned and funded by APCI. Began development of a programmable solver for VirtECS to support an unlimited number of constraints and objectives.

2010
\
2010

Innovative Breakthroughs

Partnered with Bristol Myers Squibb to develop a plant design that optimizes production at their new site in Devens, MA.

2015
\
2015

Investing in Biologics

APCI receives a NIH grant to develop a scheduling application that addresses the specific needs of biologics manufacturers.

2016
\
2016

Adding HITL Capabilities

The addition of intuitive user editing of the schedule allows for re-optimization of the schedule based on real time plant conditions.

2018
\
2018

Providing Capacity Planning Optimization

Developers update our process modeling software to accurately measure and optimize plant capacity.

Ready To Learn More?

Request a Discovery Call

VirtECSĀ® software, created by Advanced Process Combinatorics, Inc. (APCI), delivers a range of capabilities built around proprietary core solver technology. This call will allow our team to gain an initial understanding of your organization’s needs and how VirtECSĀ® can deliver results.

Complete the form and a member of our team will contact you to coordinate the most convenient option for your schedule.

 

  • This field is for validation purposes and should be left unchanged.